El.En. SpA (ELN) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

69.24 k

Shareholding (Sep 2010)

FII

0.00%

Held by 0 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.13 times

The company declared positive results in Dec'24 after negative results in Jun'24

With ROE of 0.00%, it has a Very Attractive valuation with a 2.42 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 1,037 Million ()

P/E

Industry P/E

Dividend Yield

13,046.87%

Debt Equity

-0.27

Return on Equity

0.00%

Price to Book

2.71

Revenue and Profits:

Net Sales:

50 Million

(Quarterly Results - Dec 2013)

Net Profit:

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

17.84%

6 Months

22.01%

1 Year

9.64%

2 Years

43.66%

3 Years

-9.23%

4 Years

-12.33%

5 Years

103.98%

El.En. SpA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-6.61%

EBIT Growth (5y)

-16.76%

EBIT to Interest (avg)

4.78

Debt to EBITDA (avg)

0.13

Net Debt to Equity (avg)

-0.31

Sales to Capital Employed (avg)

0.44

Tax Ratio

Dividend Payout Ratio

34.12%

Pledged Shares

Institutional Holding

0.29%

ROCE (avg)

2.29%

ROE (avg)

88.04%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.42

EV to EBIT

108.64

EV to EBITDA

70.19

EV to Capital Employed

2.94

EV to Sales

5.24

PEG Ratio

Dividend Yield

14589.34%

ROCE (Latest)

2.71%

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2010

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'13 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2013 is 0.00% vs -100.00% in Dec 2012",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2013 is 0.00% vs 0.00% in Dec 2012",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'13",
        "Dec'12",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "86.10%",
          "val2": "0.00%",
          "chgp": "8.61%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.77% vs -14.49% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.95% vs -6.44% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "565.80",
          "val2": "576.00",
          "chgp": "-1.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "84.40",
          "val2": "85.50",
          "chgp": "-1.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.40",
          "val2": "1.80",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.20",
          "val2": "0.30",
          "chgp": "2,300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "62.90",
          "val2": "55.20",
          "chgp": "13.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "131.70%",
          "val2": "132.30%",
          "chgp": "-0.06%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'13 - YoY

Dec'13

Dec'12

Change(%)

Net Sales

50.30

0.00

Operating Profit (PBDIT) excl Other Income

5.10

0.00

Interest

0.30

0.00

Exceptional Items

0.00

Consolidate Net Profit

0.00

Operating Profit Margin (Excl OI)

86.10%

0.00%

8.61%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2013 is 0.00% vs -100.00% in Dec 2012

Consolidated Net Profit

YoY Growth in quarter ended Dec 2013 is 0.00% vs 0.00% in Dec 2012

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

565.80

576.00

-1.77%

Operating Profit (PBDIT) excl Other Income

84.40

85.50

-1.29%

Interest

2.40

1.80

33.33%

Exceptional Items

7.20

0.30

2,300.00%

Consolidate Net Profit

62.90

55.20

13.95%

Operating Profit Margin (Excl OI)

131.70%

132.30%

-0.06%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -1.77% vs -14.49% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 13.95% vs -6.44% in Dec 2023

All Annual Results

Company CV

About El.En. SpA

El.En. SpA

Pharmaceuticals & Biotechnology

El En SpA is an Italy-based company primarily engaged in the production of laser systems. It controls a group of companies active in the manufacture, research, development, distribution and sale of laser equipment.The Company's range of products includes laser systems for dermatology, surgery, cosmetics, physiotherapy, dentistry and gynaecology, laser systems for cutting, marking and welding of metals, wood, plastic and glass; decoration of leather and fabrics, conservative restoration of works of art. The Company also offers accessories, after-sale services and consulting in the related areas.

Company Coordinates

Company Details

Via Baldanzese, 17 , CALENZANO None : 50041

Tel: 39 055 882680739 055 8826807

https://elengroup.com/it

Registrar Details